___

• 1. Mehmet G, Günay A, Tanık A. An evaluation of the effects of caffeic acid phenethyl ester and Ankaferd blood stopper on secondary wound healing of oral mucosal tissue. Turkish Journal of Medical Sciences 2020; 50(1): 248-257. doi: 10.3906/ sag-1908-114
• 2. Erçetin S, Haznedaroğlu İC, Mevlüt K, Önal İK, Aktaş A et al. Safety and efficacy of Ankaferd Blood Stopper in dental surgery. International Journal of Hematology and Oncology 2010; 28(4): 1-5.
• 3. Haznedaroğlu BZ, Beyazıt Y, Walker SL, Haznedaroğlu İC. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. Critical Reviews in Oncology/Hematology 2012; 83(1): 21-34. doi: 10.1016/j.critrevonc.2011.10.006
• 4. Patıroğlu T, Şahin NE, Ünal E, Kendirci M, Karakükçü M et al. Effectiveness of Ankaferd BloodStopper in prophylaxis and treatment of oral mucositis in childhood cancers evaluated with plasma citrulline levels. Turkish Journal of Hematology 2018; 35(1): 75-93. doi: 10.4274/tjh.2017.0320
• 5. Atay MH, Arslan NA, Aktimur S, Büyükkaya P, Kelkitli E et al. Safety and efficacy of ankaferd hemostat (ABS) in the chemotherapy-induced oral mucositis. International Journal of Hematology and Oncology 2015; 28(4): 166-171. https://doi. org/10.4999/uhod.15811
• 6. Chopra A, Sivaraman K. Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. Journal of Research in Pharmacy 2019; 23(5): 777-784. doi: 10.35333/jrp.2019.24
• 7. Luo L, Jin Y, Kim ID, Lee JK. Glycyrrhizin suppresses HMGB1 inductions in the hippocampus and subsequent accumulation in serum of a kainic acid-induced seizure mouse model. Cellular and Molecular Neurobiology 2014; 34(7): 987-997. doi: 10.1007/s10571-014-0075-4
• 8. Smolarczyk R, Cichoń T, Matuszczak S, Mitrus I, Lesiak M et al. The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy. Archivum Immunologiae et Therapiae Experimentalis 2012; 60(5): 391-399. doi:10.1007/s00005-012- 0183-0
• 9. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003; 361(9374): 2045-2046.
• 10. Chen G, Chen D, Li J, Czura CJ, Tracey KJ et al. Pathogenic role of HMGB1 in SARS? Medical Hypotheses 2004; 63(4): 691-695.
• 11. Kim SW, Jin Y, Shin JH, Kim ID, Lee HK et al. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiology of Disease 2012; 46(1): 147-156. doi: 10.1016/j.nbd.2011.12.056
• 12. Editorial. Redeploying plant defences. Nature Plants 2020; 6(3): 177. doi: 10.1038/s41477-020-0628-0